Company news

Theraclion SA news in 2026

Theraclion SA's news releases, calls and decks from 2026, newest first.

View company

Theraclion Announces the Initiation of Coverage by TP ICAP Midcap With a Target Price of EUR 1.70, Confirming the Potential of Sonovein®

October 28, 2026

2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development

September 16, 2026

Theraclion Initiates Its Commercial Momentum in the First Half of 2026

July 23, 2026

Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL

July 15, 2026

Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors

July 9, 2026

Theraclion Announces the Evolution of Its Board of Directors

June 18, 2026

Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code

June 8, 2026

Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China

June 4, 2026

Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein® SpeedPulse Were Presented

June 1, 2026

Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase

May 11, 2026

Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription...

April 20, 2026

Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook

April 16, 2026

Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up

January 29, 2026

Decks in 2026